Friday, 1 November 2013

Weekly Health news round up

It’s been a week where a raging storm hit the southern shores of the UK and transport came to a standstill, the ‘hacking scandal’ has finally come to court, and a proposed fizzy drink tax to tackle obesity…

Alzheimer's insight from DNA study

MS pill Tecfidera sales a triumph for Biogen

Actelion's PAH drug Opsumit recommended for EU approval

FDA suspends sale of Ariad’s cancer

29% of large trials unpublished after five years

Communicating diabetes to the online masses - how can pharma take advantage?

No comments: